Prevalence of chemokine and chemokine receptor polymorphisms in seroprevalent children with symptomatic HIV-1 infection in the United States

被引:6
作者
Singh, KK
Barroga, CF
Hughes, MD
Chen, J
Raskino, C
McKinney, RE
Spector, SA
机构
[1] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Ctr Genet Mol, La Jolla, CA USA
[3] Univ Calif San Diego, Ctr AIDS Res, San Diego, CA USA
[4] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA USA
[5] Univ Durham, Med Ctr, Durham, NC USA
关键词
chemokines; chemokine receptors; polymorphisms; HIV-1; children; race/ethnicity;
D O I
10.1097/00126334-200403010-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several chemokines and chemokine receptors are involved in HIV-1 infection, disease progression, and transmission. We studied the prevalence of genetic variations in CCR2, SDFl, and the CCR5 gene and its promoter region at positions 59029, 59353, and 59356 in a seroprevalent cohort of 1057 children with symptomatic HIV-1 infection in the United States. The percentage of children with the CCR5-wt/Delta32 genotype was significantly higher for white, non-Hispanic children (15%) than for Hispanic (6%) or black, non-Hispanic children (4%). For the CCR5-59029-GIA, CCR5-59353-T/C, and CCR5-59356-C/T polymorphisms, there were significant or marginally significant differences in genotype frequencies across race/ethnicity groups. For the CCR2-wt/641 polymorphism, both black, non-Hispanic and Hispanic children had a higher frequency of the CCR2-wt/64I genotype (24% and 21%, respectively) and CCR2-64I/64I genotype (4% and 3%, respectively) than white, non-Hispanic children (14% and 2%, respectively). For the SDFl-3'-G/A polymorphism, black, non-Hispanic children had a lower combined frequency of the SDFl-3'-G/A and SDFl-3'-A/A genotypes (15%) than did Hispanic children (33%) and white, non-Hispanic children (37%). These analyses show that the distribution of chemokine receptor and chemokine genetic polymorphisms varies significantly across race/ethnicity subgroups of HIV-1-infected children in the United States.
引用
收藏
页码:309 / 313
页数:5
相关论文
共 28 条
  • [1] The CCR5Δ32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment
    Barroga, CF
    Raskino, C
    Fangon, MC
    Palumbo, PE
    Baker, CJ
    Englund, JA
    Spector, SA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (02) : 413 - 419
  • [2] Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
    Berger, EA
    Murphy, PM
    Farber, JM
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 657 - 700
  • [3] Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age
    Buseyne, F
    Janvier, G
    Teglas, JP
    Ivanoff, S
    Burgard, M
    Bui, E
    Mayauk, MJ
    Blanche, S
    Rouzioux, C
    Rivière, Y
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (04) : 1019 - 1023
  • [4] Statistical estimation and pedigree analysis of CCR2-CCR5 haplotypes
    Clark, VJ
    Metheny, N
    Dean, M
    Peterson, RJ
    [J]. HUMAN GENETICS, 2001, 108 (06) : 484 - 493
  • [5] CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors
    Clegg, AO
    Ashton, LJ
    Biti, RA
    Badhwar, P
    Williamson, P
    Kaldor, JM
    Stewart, GJ
    [J]. AIDS, 2000, 14 (02) : 103 - 108
  • [6] Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
    Dean, M
    Carrington, M
    Winkler, C
    Huttley, GA
    Smith, MW
    Allikmets, R
    Goedert, JJ
    Buchbinder, SP
    Vittinghoff, E
    Gomperts, E
    Donfield, S
    Vlahov, D
    Kaslow, R
    Saah, A
    Rinaldo, C
    Detels, R
    OBrien, SJ
    [J]. SCIENCE, 1996, 273 (5283) : 1856 - 1862
  • [7] HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5
    Dragic, T
    Litwin, V
    Allaway, GP
    Martin, SR
    Huang, YX
    Nagashima, KA
    Cayanan, C
    Maddon, PJ
    Koup, RA
    Moore, JP
    Paxton, WA
    [J]. NATURE, 1996, 381 (6584) : 667 - 673
  • [8] Chemokine receptor polymorphisms and human immunodeficiency virus disease progression
    Easterbrook, PJ
    Rostron, T
    Ives, N
    Troop, M
    Gazzard, BG
    Rowland-Jones, SL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) : 1096 - 1105
  • [9] Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children
    Englund, JA
    Baker, CJ
    Raskino, C
    McKinney, RE
    Lifschitz, MH
    Petrie, B
    Fowler, MG
    Connor, JD
    Mendez, H
    ODonnell, K
    Wara, DW
    Shliozberg, J
    Shearer, WT
    Stechenberg, B
    Borkowsky, W
    Bonaforte, RJ
    Cooper, ER
    Wiznia, A
    Toltzis, P
    Israele, V
    VanDyke, RB
    Yogev, R
    Starr, S
    Oleske, F
    Frenkel, L
    McIntosh, K
    Montgomery, M
    Petru, A
    Squires, JE
    Wade, N
    Moore, EC
    Rakusan, TA
    Baker, RC
    Brady, MT
    Pildes, RS
    Cervia, JS
    Wilfert, C
    Nesheim, S
    Bellanti, JA
    Keller, M
    Abrams, EJ
    Dossett, JH
    Rana, SR
    Tishler, DM
    Nicholas, SW
    Lambert, JS
    Wong, V
    Gupta, A
    Deveikis, A
    Kovacs, A
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (11) : 1025 - 1036
  • [10] Effects of CCR5-Δ32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children:: an international meta-analysis
    Ioannidis, JPA
    Contopoulos-Ioannidis, DG
    Rosenberg, PS
    Goedert, JJ
    De Rossi, A
    Espanol, T
    Frenkel, L
    Mayaux, MJ
    Newell, ML
    Pahwa, SG
    Rousseau, C
    Scarlatti, G
    Sei, S
    Sen, L
    O'Brien, TR
    [J]. AIDS, 2003, 17 (11) : 1631 - 1638